How Is Acute Myeloid Leukemia Diagnosed?

This content has been reviewed and approved by

Hagop M. Kantarjian, MD
Chairman & Professor, Leukemia Department
MD Anderson Cancer Center
University of Texas
 

In addition to a complete medical history and physical examination, diagnostic procedures for acute myeloid leukemia (AML) may include the following:

  • Additional blood tests and other evaluation procedures
      
  • Bone marrow aspiration and/or biopsy - a procedure that involves taking a small amount of bone marrow fluid (aspiration) and/or solid bone marrow tissue (called a core biopsy). The fluid and tissue usually come from the hip bones. They are examined for the number, size, and maturity of blood cells and/or abnormal cells. It is also used to do the chromosome analysis on these cells.
      
  • Spinal tap/lumbar puncture - This is only done in special cases when there is suspicion that the leukemia may have involved the brain. This is rarely discovered at the time of diagnosis, perhaps in only 1 percent of cases. A special needle is placed through the lower back into the spinal canal. The canal is the area around the spinal cord. The pressure in the spinal canal and brain can then be measured. A small amount of cerebral spinal fluid (CSF) can be removed and sent for testing to determine if there is an infection or other problems. CSF is the fluid that bathes the brain and spinal cord. 

 

This content was last modified on August 11, 2007 .
Latest Acute Myeloid Leukemia News
Birth weight appears associated with leukemia

July 2, 2009 — NEW YORK (Reuters Health) - There may be an association between high birth weight and an increased risk of overall leukemia and acute lymphoblastic leukemia (ALL). The increased risk of acute myeloid leukemia (AML) appears to be associated with the high and low extremes of birth weight.

Most patients want cancer prognosis test

June 16, 2009 — NEW YORK (Reuters Health) - Most patients with a form of eye cancer called choroidal melanoma want to undergo a genetic test that can predict their likely outcome, a small study suggests.

Obesity does not affect leukemia treatment

December 9, 2008 — NEW YORK (Reuters Health) - Obesity has little impact on the success of blood cell transplants for acute myeloid leukemia, the most common reason for performing such transplantations, according to study findings presented at the American Society of Hematology annual meeting in San Francisco.

Select news items provided by Reuters Health